As children with type 1 diabetes return to school, experts highlight the importance of personalised care plans, staff training, and collaborative support to manage the condition effectively within educational environments. For children with type 1 diabetes, the return to school…
As children return to school, experts highlight the importance of personalised plans and staff training to ensure safe and inclusive diabetes care, addressing persistent gaps in support and communication. For families of children with type 1 diabetes, the start of…
Argentina’s medicines regulator has issued a nationwide ban on products claiming to contain retatrutide, a weight-loss substance under investigation, amid rising online sales and health risks. Argentina’s medicines regulator has banned the sale, promotion and distribution of products that claim…
A three-year study reveals that slight weight regain following tirzepatide therapy does not significantly diminish its positive effects on blood sugar and other metabolic markers in individuals with obesity and prediabetes. A three-year analysis from the SURMOUNT-1 trial suggests that…
A small trial indicates that men with type 2 diabetes may have a blunted physiological response to oral sodium intake, highlighting potential disruptions in gut-kidney communication and implications for blood pressure management. A small crossover trial in men with type…
A landmark study in England shows that even as below-knee amputations among people with diabetes decline, survival post-surgery remains critically poor, with over 80% dead within ten years and high short-term complications, highlighting the urgent need for improved post-amputation care.…
New studies suggest that non-caloric sweeteners like saccharin and sucralose may alter gut bacteria and affect glucose handling, with effects varying between individuals and raising concerns over long-term health impacts. Researchers have added to a growing body of evidence suggesting…
Hikma Pharmaceuticals enters the booming GLP-1 market with the launch of Glucentra, the first generic semaglutide available in Saudi Arabia, signalling a strategic shift towards innovation and pipeline growth. Hikma Pharmaceuticals has moved into the fast-growing market for GLP-1 medicines…
Biolinq’s needle-free Shine wearable has received FDA approval for over-the-counter use, marking a significant step in consumer glucose monitoring and challenging traditional medical device regulations. Biolinq Incorporated said on Thursday that the US Food and Drug Administration has cleared its…
New research indicates that dining with close companions can enhance blood sugar management and improve overall physiological responses, challenging traditional views of human physiology. New research from the Hebrew University of Jerusalem suggests that sharing a meal with someone close…
